DocWire News EditorsDemodex Blepharitis | July 11, 2024
A panel of experts discusses lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis.
View More
DocWire News EditorsDemodex Blepharitis | July 11, 2024
An ophthalmology panel explains the pros and cons of the current standard of care for treating Demodex blepharitis.
DocWire News EditorsDemodex Blepharitis | July 11, 2024
A panel of experts discusses how Demodex blepharitis presents and what treatment options are typically used.
DocWire News EditorsDemodex Blepharitis | July 11, 2024
A panel provides a breakdown on Demodex blepharitis, a prevalent ocular disease caused by an infestation of Demodex mites.
Rob DillardADA 2024 | June 21, 2024
Fenofibrate significantly reduces the progression of diabetic retinopathy.
Rob DillardOphthalmology | January 25, 2024
Researchers developed a contact lens that can potentially diagnose glaucoma by detecting changes in eye pressure.
Rob DillardOphthalmology | January 19, 2024
Researchers have identified several novel gene variants related to the formation of glaucoma in Black people.
Patrick DalyOphthalmology | May 31, 2023
A study found unique risk factors for cardiovascular disease and mortality in patients with age-related macular degeneration.
Rob DillardOphthalmology | May 16, 2023
Black and Hispanic patients face disparities when it comes to firearms-associated ocular injuries.
Rob DillardOphthalmology | March 10, 2023
A team of researchers from the Indiana University School of Medicine have pinpointed a new therapeutic target that may ...
Patrick DalyOphthalmology | June 28, 2023
Research has suggested that sarcolemmal membrane-associated protein (SLMAP) is a driver in microvascular endothelial ...
Patrick DalyOphthalmology | October 31, 2022
Researchers, led by Takashi Nishida, MD, PhD, investigated the association between intraocular pressure variation and ...
Patrick DalyOphthalmology | October 26, 2022
Researchers investigated the impact of dual antiplatelet therapy on the progression of geographic atrophy (GA) in ...
Patrick DalyOphthalmology | October 19, 2022
In a recent randomized clinical trial in BMC Ophthalmology, researchers explored the potential of 1.0% phentolamine ...
Patrick DalyEndocrinology | April 10, 2023
In a study published in the Journal of Glaucoma, researchers evaluated the incidence of ocular hypertension in patients ...
Cailin ConnerOphthalmology | September 19, 2022
For many children, wearing the correct glasses is crucially important to ensuring lifelong, healthy vision. While ...
DocWire News EditorsOphthalmology | April 28, 2023
Ehsan Rahimy, MD, moderates a discussion about hands-on experience with port delivery systems for patients with ...
DocWire News EditorsOphthalmology | April 28, 2023
In this segment of the round table series, moderator Ehsan Rahimy, MD, and panelists discuss the findings from the ...
DocWire News EditorsOphthalmology | April 28, 2023
The panel discusses the advancements they are most looking forward to in the neovascular AMD space, from new treatments ...
Rob DillardOphthalmology | August 1, 2023
A recent survey conducted by The Harris Poll on behalf of Apellis Pharmaceuticals found that geographic atrophy (GA) – ...
Latest News

July 18, 2024